stella
beta
Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant OCD — Stella
Recruiting
Back to Obsessive-Compulsive Disorder trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
Canada
Centre for Addiction and Mental Health, Toronto, Ontario
View full record on ClinicalTrials.gov